Journals / İstanbul Kuzey Klinikleri / 2020 / Cilt: 7 - Sayı: 4

The effects of resveratrol treatment on caveolin-3 expression and $Na^+$ /$K^+$ ATPase activity in rats with isoproterenol-induced myocardial injury

Pages
313–320
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the light of above-mentioned data, RES can be assumed as a promising agent in ameliorating theoxidative injury of the myocardium.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: The present study aims to investigate the therapeutic effects of resveratrol (RES) on isoproterenol (ISO) induced myocardial injury rat model.METHODS: Catecholamine-induced heart damage was induced by ISO treatment for 30 days.
📊
Key Findings & Data:The rats were divided intofour groups as follows: the control group received saline, the ISO group received 5.0 mg/kg ISO, the RES group received 10mg/kg RES, and the ISO-RES group received 10 mg/kg RES and 5 mg/kg ISO treatments for 30 days.
💡
Conclusion & Impact:In the light of above-mentioned data, RES can be assumed as a promising agent in ameliorating theoxidative injury of the myocardium.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: The present study aims to investigate the therapeutic effects of resveratrol (RES) on isoproterenol (ISO) induced myocardial injury rat model.METHODS: Catecholamine-induced heart damage was induced by ISO treatment for 30 days. The rats were divided intofour groups as follows: the control group received saline, the ISO group received 5.0 mg/kg ISO, the RES group received 10mg/kg RES, and the ISO-RES group received 10 mg/kg RES and 5 mg/kg ISO treatments for 30 days. Following echocardiographic measurements and body weight recorded, the rats were decapitated. Plasma and cardiac tissue samples obtained bydecapitation were analyzed using biochemical, histopathological, molecular and immunohistochemical methods.RESULTS: In the ISO group, Na+/K+ ATPase activity and ATP content, GSH, and caveolin-3 levels were low. LDH, CK and lysosomal enzyme activities, MDA level, and MPO activity were found to be high. It was determined that GSH and MDA levels and MPO,Na+/K+ ATPase activity, ATP content caveolin-3 levels changes that arose from ISO treatment were suppressed by RES treatment.CONCLUSION: RES treatment has ameliorated all the functional and biochemical parameters. The results obtained in thisstudy suggest that RES is a promising supplement against catecholamine exposure as it improves antioxidant defense mechanisms in the heart. In the light of above-mentioned data, RES can be assumed as a promising agent in ameliorating theoxidative injury of the myocardium.

🔖

Cite This Article

ÖZKAN, N., AKKİPRİK, M., ÇETİNEL, Ş., ŞENER, G., TETİK, Ş., YİĞİNER, Ö., TEZCAN, M., AYKAÇ, A., KAYA, Z., ŞEHİRLİ, A. Ö., YEGEN, B. Ç. (2022). The effects of resveratrol treatment on caveolin-3 expression and $Na^+$ /$K^+$ ATPase activity in rats with isoproterenol-induced myocardial injury. İstanbul Kuzey Klinikleri, Cilt: 7 - Sayı: 4, 313–320. https://ajindex.com/articles/551388

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hoffstein S, Gennaro DE, Weissmann G, Hirsch J, Streuli F, Fox AC. Cytochemical localization of lysosomal enzyme activity in normal and ischemic dog myocardium. Am J Pathol 1975;79:193–206
  2. Padmanabhan M, Prince PS. Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: a histopathological study. Toxicology 2006;224:128–37
  3. Wexler BC. Myocardial infarction in young vs old male rats: pathophysiologic changes. Am Heart J 1978;96:70–80
  4. Das DK, Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv 2006;6:36–47
  5. Dikshit M, Van Oosten MH, de Graff S, Srimal RC. Free radical scavenger mechanisms in experimentally induced ischemia in the rabbit heart and protective effect of verapamil. Arch Int Pharmacodyn Ther 1992;318:55–65
  6. Verdejo HE, del Campo A, Troncoso R, Gutierrez T, Toro B, Quiroga C, et al. Mitochondria, myocardial remodeling, and cardiovascular disease. Curr Hypertens Rep 2012;14:532–9
  7. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493–506
  8. Tatlidede E, Sehirli O, Velioğlu-Oğünc A, Cetinel S, Yeğen BC, Yarat A, et al. Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage. Free Radic Res 2009;43:195–205
  9. Toklu HZ, Sehirli O, Erşahin M, Süleymanoğlu S, Yiğiner O, Emekli-Alturfan E, et al. Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats. J Pharm Pharmacol 2010;62:1784–93
  10. Mészáros J, Khananshvili D, Hart G. Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats. Am J Physiol Heart Circ Physiol 2001;281:H903–14
  11. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358–67
  12. Park K, Chang SA, Kim HK, Park HE, Na SH, Kim YJ, et al. Normal ranges and physiological changes of midwall fractional shortening in healthy korean population. Korean Circ J 2010;40:587–92
  13. Beutler E. A Manual of Biochemical Methods. In: Glutathione in Red Blood Cell Metaboli